Teves, Alrenze .
HRN: 13-26-88 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2022
CEFTRIAXONE 1G (VIAL)
05/22/2022
05/22/2022
IV
2g
OD
Traumatic Brain Injury
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes